Article Text

Download PDFPDF
Review: angiotensin-converting enzyme inhibitors reduce the progression of non-diabetic renal disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Sources of funding: National Institute of Diabetes and Digestive and Kidney Diseases; Agency for Healthcare Research and Quality; Dialysis Clinic, Inc.; Paul Teschan Research Fund; New England Medical Center–St. Elizabeth's Hospital Medical Center Clinical Research Fellowship Program; Merck Research Laboratories.

  • For correspondence: Dr A S Levey, Division of Nephrology, New England Medical Center, 750 Washington Street, Box 391, Boston, MA 02111, USA. Fax +1 617 636 8329.